Tirzepatide acts on two (GLP-1 and GIP), which in clinical studies has been associated with greater average weight loss
The glucagon-like peptide-1 receptor agonists (GLP-1 RAs), and now next-generation multi-agonists that include GLP-1 activity, are producing average weight reductions far larger than previously expected from drugs, reshaping clinical practice and how clinicians and patients think about obesity treatment
Well take the time to discuss your medical history, current medications, and overall rehabilitation goals to create a plan that supports your long-term health and well-being
More than half of GLP-1 users (52%) say they spend less money eating out than they used to, and 42% say they have reduced or eliminated the amount they used to spend on other weight loss programs or methods
Linge J, Birkenfeld AL, Neeland IJ
Eating low and slow also helps